FDA Adverse Event Malfunction Summary report: N

UNICEL® DXC 600 PRO SYNCHRON® CHEMISTRY ANALYZER

MDR report key: 1853402 · Received October 5, 2010

Report

Report Number
2050012-2010-00928
Event Type
Malfunction
Date Received
October 5, 2010
Date of Event
September 9, 2010
Report Date
October 4, 2010
Manufacturer
BECKMAN COULTER INC.
Product Code
JJE
PMA / PMN Number
K042291
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
GA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE SAMPLE WAS DRAWN IN A B-D LITHIUM HEPARIN GEL SEPARATOR PLASMA PLASTIC TUBE AND CENTRIFUGED AT 3600 RPM AT ROOM TEMPERATURE IN A SWINGING BUCKET CENTRIFUGE. CRP WAS CALIBRATED AND QC RESULTS, PRIOR TO AND AFTER THE EVENT, WERE WITHIN THE LAB'S ESTABLISHED RANGES. THE CUSTOMER CONTACTED THE BCI HOTLINE BECAUSE THERE WAS A SHIFT IN QC RESULTS WHEN CRP REAGENT WAS PUT INTO USE. THE SHIFTS ON 2 QC SAMPLES WERE WITHIN THE LAB'S ESTABLISHED QC RANGES. A CONTROL SAMPLE WAS SENT TO THE CUSTOMER FOR TROUBLESHOOTING. THE CONTROL RECOVERED WITHIN RANGE. SERVICE WAS NOT REQUESTED FOR THIS EVENT. THE ERROR WAS NOT REPRODUCIBLE AND LIMITED TO ONE PATIENT SAMPLE. A ROOT CAUSE WAS NOT IDENTIFIED.

Description of Event or Problem · 1

A CUSTOMER CONTACTED BECKMAN COULTER INC. (BCI) REGARDING AN ERRONEOUSLY HIGH C-REACTIVE PROTEIN (CRP) RESULT THAT WAS GENERATED BY THE UNICEL DXC 600 PRO SYNCHRON CHEMISTRY ANALYZER ON ONE PATIENT SAMPLE. SUBSEQUENT TESTING ON AN ALTERNATE INSTRUMENT PRODUCED A LOWER RESULT. THE ERRONEOUS RESULT WAS REPORTED OUTSIDE THE LABORATORY, BUT WAS AMENDED BY THE SUBSEQUENT RESULT. THE CUSTOMER HAS NOT RECEIVED ANY REPORT OF PATIENT INJURY REQUIRING MEDICAL INTERVENTION OR CHANGE TO PATIENT TREATMENT ATTRIBUTED TO OR CONNECTED WITH THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 UNICEL® DXC 600 PRO SYNCHRON® CHEMISTRY ANALYZER CLINICAL CHEMISTRY ANALYZER JJE BECKMAN COULTER INC. DXC 600 PRO N/A

Patients

Seq Age Sex Outcome Treatment
1 51 YR